Skip to content

Repetitive Transcranial Magnetic Stimulation and Paired Associative Stimulation for Tourette Syndrome

Repetitive Transcranial Magnetic Stimulation and Paired Associative Stimulation for Tourette Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017143
Enrollment
Unknown
Registered
2018-07-13
Start date
2018-07-13
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tourette Syndrome

Interventions

PAS-25:paired associative stimulation, interval of 25 milliseconds
PAS-50:paired associative stimulation, interval of 50 milliseconds
false stimulation:false stimulation

Sponsors

Capital Medical University Affiliated Xuanwu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 40 Years

Inclusion criteria

Inclusion criteria: gender unlimited, aged 6-40 years; patients did not take any anti-TS drugs or change the type and dose of anti-TS drugs in his or her latest month; physical examination of nervous system shows no positive signs; no other chronic disease, YGTSS score above 25

Exclusion criteria

Exclusion criteria: The type and dose of oral medication change during the treatment or within one month after the end of treatment; secondary treatment of TS; severe circulatory, respiratory, metabolic disease, epilepsy, traumatic brain injury; drugs that affect the excitability of the cerebral cortex, coffee and tea have been taken; Patients with metal in the body, or pregnant, or while breastfeeding

Design outcomes

Primary

MeasureTime frame
Yale Global Tie Severityb Scale;

Countries

China

Contacts

Public ContactYuping Wang

Capital Medical University Affiliated Xuanwu Hospital

wangyuping01@sina.cn+86 010-83198273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026